Search

Search Results

• 

  PO29 | CANADIAN INSIGHTS INTO THE MANAGEMENT OF BREAKTHROUGH THROMBOSIS S. Ramdani¹, C. Séguin² | ¹Division of Hematology, Post-Graduate Medical Education Program, McGill University, Montreal; ²Division of Hematology, Department of Medicine, McGill University Health Center, Montreal, Canada

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.524

  251

  PDF: 68

• CO08 | The utility of urine qualitative assessment for direct oral anticoagulants in routine clinical practice F. Schieppati^1,2, P. Gomez-Rosas^1,3, C. Ambaglio¹, V. Brusegan¹, Oc. Cretu^1,2, E. Galimberti¹, F. Zunino¹, L. Barcella¹, J. Harenberg^4,5, A. Falanga^1,2, M. Marchetti^1,2 | ¹Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; ⁴Ruprecht Karls University of Heidelberg, Germany; ⁵Germany DOASENSE GmbH, Heidelberg, Germany

  22-10-2025

  https://doi.org/10.4081/btvb.2025.212

  669

  PDF: 0
• 

  OC02 | INCIDENCE AND PREDICTORS OF ARTERIAL THROMBOSIS IN CANCER PATIENTS: RESULTS FROM THE PROSPECTIVE COMPASS-ARTERIAL CANCER ASSOCIATED THROMBOSIS (COMPASS-ARTECAT) STUDY M. Drakopoulou¹, I. Diamandoulaki², P. Baglaridis¹, P. Las Casa³, P. Van Dreden⁴, K. Toutouzas¹, G. Gerotziafas^4|5 | ¹First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece; ²Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece; ³Sorbonne University, INSERM UMR_S_938, CRSA, Research Department "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Haemostasis," Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France; ⁴Diagnostica Stago, clinical research, Gennevilliers, France; ⁵Center of Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Ill., USA

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.486

  266

  PDF: 81

• PO70 | Clinical safety and monitoring of apixaban combined with tacrolimus and everolimus in kidney transplant patients: a prospective study S. Guglielmo¹, E. De Bon², L. Scarano¹, R. Fabris¹, E. Pierobon³, S. Barbar² | ¹Internal Medicine, Department of Medicine, Azienda ULSS 6 Euganea, Cittadella; ²Thrombotic and Hemorrhagic Disorders Unit, Department of Medicine, Azienda ULSS 6 Euganea, Cittadella; ³Nephrology and Dialysis Unit, Azienda ULSS 6 Euganea, Cittadella and Camposampiero, Padova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.339

  555

  PDF: 0
• 

  Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

  Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

  16-05-2024

  https://doi.org/10.4081/btvb.2024.120

  1680

  PDF: 665
• 

  Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

  Giovanni Tiscia, Elvira Grandone

  13-09-2022

  https://doi.org/10.4081/btvb.2022.43

  2611

  PDF: 397
• 

  PO11 | THROMBOEMBOLIC EVENTS DURING PERIOPERATIVE THERAPY FOR RESECTABLE AND BORDERLINE RESECTABLE PANCREATIC CANCER IN THE PREOPANC-2 TRIAL R.A.L. Willems^1|5, A.E. Van Diepen^1|2|6, EN. Dekker⁷, Q.P. Janssen⁷, J.L. Van Dam⁷, N. Michiels⁸, C.W.F. Van Eijck⁹, K.E.P.E. Hermans^1|2, B.A. Bonsing⁸, K.P. Bosscha¹⁰, S.A.W. Bouwense^11|12, O. R. Busch^13|14, H. Ten Cate^4|5|15|16, P.P.L.O. Coene¹⁷, C.H.J. Van Eijck⁷, N. Van Es^18|19, E. Van Der Harst¹⁷, I.H.J.T. De Hingh²⁰, T.M. Karsten²¹, G. Kazemier^13|14, M.B. Van Der Kolk²², B. De Laat^3|5, M.S.L. Liem²², J.S.D. Mieog⁸, V.B. Nieuwenhuijs²⁴, G.A. Patijn²⁴, M. Roest³, H.C. Van Santvoort²⁵, L. Valkenburg-Van Iersel^1|2, R. F. De Wilde⁷, F. Wit²⁶, B.M. Zonderhuis^13|14, M.G. Besselink^13|14, M.Y.V. Homs⁶, G. Van Tienhoven^14|27, J. W. Wilmink^14|28, B. Groot Koerkamp⁷, J. De Vos-Geelen^1|2 | ¹Maastricht University Medical Center, Department of Internal Medicine, Division of Medical Oncology; ²GROW – Research Institute for Oncology & Reproduction, Maastricht University, Maastricht; ³Synapse Research Institute, Department of Functional Coagulation, Maastricht; ⁴Maastricht University Medical Center, Thrombosis Expert Center Maastricht, Maastricht; ⁵Maastricht University Medical Center, Cardiovascular Research Institute Maastricht (CARIM), School for Cardiovascular Diseases, Maastricht; ⁶Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam; ⁷Erasmus MC Cancer Institute Rotterdam, University Medical Center Rotterdam, Department of Surgery; ⁸Leiden University Medical Center, Department of Surgery, Leiden; ⁹Solid Tumour Immunology Research Rotterdam (STIRR), Department of Pulmonary Medicine, Erasmus University Medical Centre, Rotterdam; ¹⁰Jeroen Bosch Hospital, Department of Surgery, Den Bosch; ¹¹Maastricht University Medical Center, Department of Surgery, Maastricht; ¹²Maastricht University Medical Center, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht; ¹³Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam; ¹⁴Cancer Center Amsterdam; ¹⁵Maastricht University Medical Center, Department of Internal Medicine, Division Vascular Medicine, Maastricht; ¹⁶Maastricht University, Department of Biochemistry, Laboratory for Clinical Thrombosis and Hemostasis, Maastricht; ¹⁷Maasstad Hospital, Department of Surgery, Rotterdam; ¹⁸Amsterdam UMC, location University of Amsterdam, Department of Vascular Medicine, Amsterdam; ¹⁹Amsterdam UMC, location University of Amsterdam, Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam; ²⁰Catharina Hospital, Department of Surgery, Eindhoven; ²¹OLVG, Department of Surgery, Amsterdam; ²²Radboud University Medical Center, Department of Surgery, Nijmegen; ²³Medisch Spectrum Twente, Department of Surgery, Enschede; ²⁴Isala Oncology Center, Department of Surgery, Zwolle; ²⁵Regional Academic Cancer Center Utrecht, St. Antonius Hospital and University Medical Center Utrecht, Department of Surgery, Utrecht; ²⁶Frisius MC, location Leeuwarden, Department of Surgery, Leeuwarden; ²⁷Amsterdam UMC, location University of Amsterdam, Department of Radiation Oncology, Amsterdam; ²⁸Amsterdam UMC, location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.507

  234

  PDF: 52

• PO93 | Use of DOACS in heart transplantation recipients T. Marrazzo¹, A. Delle Femine¹, C. Amarelli², R. Albisinni³ | ¹UOC Medicina Interna e dei Trapianti, Ospedale Monaldi Azienda dei Colli, Napoli; ²UOSD CCH dei Trapianti, Ospedale Monaldi Azienda dei Colli, Napoli; ³UOC CCH Generale, Ospedale Monaldi Azienda dei Colli, Napoli, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.363

  663

  PDF: 0

• CS01 | Elucidating the evil relationship of metabolic dysfunction–associated fatty liver disease with cardiovascular comorbidities: the complex interplay among hypercoagulability, inflammation and liver fibrosis G. Gagliardi, E. Campello, A. Napolitano, B. Stocco, C. Di Gesù, G. Gobbo, I. Condonato, M. Allegra, G. Camporese, P. Scarinzi, R. Pesavento, F. Bilora, C. Bulato, A. Benetti, C. Samà, C. Portinari, G. Antonello, C. Goffi, L. Di Daniel, A. Zambon, L. Fabris, P. Simioni | First Chair of Internal Medicine, Department of Medicine, University-Hospital of Padua Medical School, Padua, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.196

  739

  PDF: 0

• PO37 | Single centre experience on anticoagulation in carriers of non-mild inherited thrombophilia: direct oral anticoagulants (DOAC) efficacy and safety M. D’uva^1,2, G. La Barba¹, G. Montanaro¹, M. Di Ianni^1,2, P. Ranalli^1,2 | ¹Hematology Unit, S. Spirito Hospital, Pescara; ²Department of Medicine and Aging Sciences, D’Annunzio University, Chieti, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.300

  578

  PDF: 0
• 

  PO27 | URINE QUALITATIVE ASSESSMENT OF DIRECT ORAL ANTICOAGULANTS IN ROUTINE CLINICAL PRACTICE F. Schieppati^1|2, P. Gomez-Rosas^1|3, C. Ambaglio¹, V. Brusegan¹, O.C. Cretu¹, E. Galimberti¹, F. Zunino¹, L. Barcella¹, J. Harenberg^4|5, A. Falanga^1|2, M. Marchetti^1|2 | ¹Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; ³Maastricht University Medical Center, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands; ⁴Ruprecht Karls University of Heidelberg, Heidelberg, Germany; ⁵DOASENSE GmbH, Heidelberg, Germany

  Società Italiana di Emostasi e Trombosi

  16-04-2026

  https://doi.org/10.4081/btvb.2026.522

  198

  PDF: 70
• 

  Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers

  Ezio Zanon, Giancarlo Castaman, Augusto Bramante Federici, Maria Elisa Mancuso, Gianfranco Pasut, Alberto Tosetto, Angiola Rocino, Rita Carlotta Santoro

  26-01-2026

  https://doi.org/10.4081/btvb.2026.415

  1099

  PDF: 291

  HTML: 117

• CO06 | Recurrences of catheter associated upper extremity deep vein thrombosis in cancer: a two year prospective study with enoxaparin M. Sartori, A. Trentini, S. Cavara, L. Borgese, M. Soldati, B. Cosmi | Angiology and Blood Coagulation Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.210

  594

  PDF: 0